Bavarian Nordic A/S
BAVA
Kedudukan dalam Saham
#5045
Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in... Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in the research, production, and global distribution of vital, life-saving vaccines. The company's commercialized offerings include non-replicating vaccines for smallpox and monkeypox, marketed as IMVAMUNE, IMVANEX, and JYNNEOS. Additionally, their portfolio features Rabipur/RabAvert for rabies prevention, Encepur for tick-borne encephalitis, and MVABEA, an Ebola vaccine. Bavarian Nordic also maintains a robust pipeline of investigational treatments. This includes MVA-BN (freeze-dried), which has successfully completed Phase III clinical trials for smallpox; MVA-BN RSV, currently in Phase III development for respiratory syncytial virus; ABNCoV2, which completed Phase II trials targeting SARS-CoV-2; and TAEK-VAC, presently in Phase I/II trials for advanced HER2 and brachyury-expressing cancers. The firm engages in key partnerships, notably a license and collaboration agreement with AdaptVac, and licensing agreements with both the National Cancer Institute and the Public Health Service. Bavarian Nordic operates across a wide international footprint, with a presence in countries such as the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and numerous other global markets.
Harga Saham
$37.76
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$2.87B
Perubahan (1 hari)
-0.17%
Perubahan (1 tahun)
1.44%
Negara
DK
Perdagangan Bavarian Nordic A/S (BAVA)
Kategori
Healthcare
Modal pasaran bagi Bavarian Nordic A/S(BAVA)
Modal Pasaran: $2.87B
Sehingga October 2026, Bavarian Nordic A/S mempunyai modal pasaran sebanyak $2.87B. Ini menjadikan Bavarian Nordic A/S syarikat ke-5045th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Bavarian Nordic A/S dari 2003 hingga 2026
BAVA berbanding dengan 5 teratas yang paling popular stocks
